MENU
CRDL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cardiol Therapeutics (CRDL) Earnings Date & Reports

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more

A.I. Advisor
published Earnings

CRDL is expected to report earnings to rise 39.44% to -9 cents per share on August 18

Cardiol Therapeutics CRDL Stock Earnings Reports
Q2'25
Est.
$-0.10
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.05
Q2'24
Beat
by $0.03
The last earnings report on May 16 showed earnings per share of -7 cents, beating the estimate of -9 cents. With 4.33M shares outstanding, the current market capitalization sits at 124.33M.
View a ticker or compare two or three
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRDL showed earnings on May 16, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
2265 Upper Middle Road East
Phone
+1 289 910-0850
Employees
22
Web
https://www.cardiolrx.com